Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PIK3CA Mutation Status as a Biomarker in Elderly Women With Breast Cancer

NCT01346579 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT01346579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01346579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PIK3CA Mutation Status as a Biomarker in Elderly Women With Breast Cancer
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Observational
Overall status
Terminated
Start date
April 30, 2011
Completion date
January 31, 2014
Enrollment
505 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer